Mallinckrodt last month successfully completed its tender offer for the common stock of Nellcor Puritan Bennett (SCAN 8/6/97). St. Louis-based Mallinckrodt accepted payment for about 59.1 million Nellcor shares representing more than 90% of Nellcor's
Mallinckrodt last month successfully completed its tender offer for the common stock of Nellcor Puritan Bennett (SCAN 8/6/97). St. Louis-based Mallinckrodt accepted payment for about 59.1 million Nellcor shares representing more than 90% of Nellcor's shares outstanding. Mallinckrodt said it expects to close the deal shortly.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.